Bisel v. Acasti Pharma, Inc
Bisel v. Acasti Pharma, Inc is a federal securities / commodities lawsuit filed on 07/14/2021 in the District Court, S.D. New York. The case was terminated on 09/28/2022.
- Court
- District Court, S.D. New York (S.D.N.Y.)
Official Court Website → - Assigned judge
- Katherine Polk Failla · 2,132 cases in index
- Docket number
- 1:21-cv-06051
- Cause
- 15:78m(a) Securities Exchange Act
15 U.S.C. § 78m - Nature of suit
- 850 Securities/Commodities
Alleged violations of federal securities or commodities laws. - Jurisdiction
- Federal Question
- Jury demand
- Plaintiff
- Date filed
- 07/14/2021
- Date terminated
- 09/28/2022
13,858 Securities / Commodities cases in this court are indexed here.
Parties
- plaintiff · Bisel · 13 cases
- defendant · Acasti Pharma, Inc · 3 cases
Part of a Larger Litigation Pattern
This is one of 4 Securities / Commodities cases in our index naming Acasti Pharma, Inc — a possible mass-tort or coordinated-litigation cluster.
About Securities / Commodities Lawsuits
Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.
Frequently Asked Questions
What is Bisel v. Acasti Pharma, Inc?
Bisel v. Acasti Pharma, Inc is a federal securities / commodities lawsuit filed on 07/14/2021 in the District Court, S.D. New York. The case was terminated on 09/28/2022. Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.
What type of case is this?
It is classified as “Securities / Commodities” under the federal nature-of-suit system. Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.
What court is the case in?
The case is in the District Court, S.D. New York, docket number 1:21-cv-06051.
When was the case filed?
Bisel v. Acasti Pharma, Inc was filed on 07/14/2021. It was terminated on 09/28/2022.
What law is the case brought under?
The docket lists the cause as 15 U.S.C. § 78m.
Other Cases Involving These Parties
Related Securities / Commodities Cases
Source: public U.S. federal court record (docket 60058741).